Abstract
To evaluate the efficacy and safety of an expanded polytetrafluoroethylene-fluorinated ethylene-propylene (ePTFE/FEP)-covered metallic stent in the management of malignant biliary obstruction. Eighty consecutive patients with malignant common bile duct strictures were treated by placement of 83 covered metallic stents. The stent-graft consists of an inner ePTFE/FEP lining and an outer supporting structure of nitinol wire. Clinical evaluation, assessment of serum bilirubin and liver enzyme levels were analyzed before biliary drainage, before stent-graft placement and during the follow-up period at 1, 3, 6, 9 and 12 months. Technical success was obtained in all cases. After a mean follow-up of 6.9±4.63 months, the 30-day mortality rate was 14.2%. Survival rates were 40% and 20.2% at 6 and 12 months, respectively. Stent-graft patency rates were 95.5%, 92.6% and 85.7% at 3, 6 and 12 months, respectively. Complications occurred in five patients (6.4%); among these, acute cholecystitis was observed in three patients (3.8%). A stent-graft occlusion rate of 9% was observed. The percentage of patients undergoing lifetime palliation (91%) and the midterm patency rate suggest that placement of this ePTFE/FEP-covered stent-graft is safe and highly effective in achieving biliary drainage in patients with malignant strictures of the common bile duct.
Similar content being viewed by others
References
Gillams A, Dick R, Dooley JS, Wallsten H, El-Dim A (1990) Self-expandable stainless steel braided endoprostheses for biliary strictures. Radiology 174:137–140
Kaskarelis IS, Papadaki MG, Papageorgiou GN, Limniati MD, Malliaraki NE, Piperopoulos PN (1999) Long-term follow-up in patients with malignant biliary obstruction after percutaneous placement of uncovered Wallstent endoprostheses. Acta Radiol 40:528–533
Tesdal IK, Adamus R, Poeckler C, Koepke J, Jaschke W, Georgi M (1997) Therapy for biliary stenoses and occlusions with use of three different metallic stents: single-center experience. J Vasc Interv Radiol 8:869–879
Lee BH, Choe DH, Lee JH, Kim KH, Chin SY (1997) Metallic stents in malignant biliary obstruction: prospective long-term clinical results. AJR Am J Roentgenol 168:741–745
Thurnher SA, Lammer J, Thurnher MM, Wilkenbauer F, Graf O, Wildling R (1996) Covered self-expanding transhepatic biliary stents: clinical pilot study. Cardiovasc Intervent Radiol 19:10–14
Lammer J, Hausegger KA, Flückiger F et al (1996) Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology 201:167–172
Shim CS, Lee JH, Cho JD et al (1998) Preliminary results of a new covered biliary metal stent for malignant biliary obstruction. Endoscopy 30:345–350
Rossi P, Bezzi M, Rossi M et al (1994) Metallic stents in malignant biliary obstruction: results of multicenter European study of 240 patients. J Vasc Interv Radiol 5:279–285
Gordon RL, Ring EJ, LaBerge JM, Doherty MM (1992) Malignant biliary obstruction: treatment with expandable metallic stents-follow-up of 50 consecutive patients. Radiology 182:697–701
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
Dick BW, Gordon RL, La Berge JM, Doherty M, Ring EJ (1990) Percutaneous transhepatic placement of biliary endoprostheses: results in 100 consecutive patients. J Vasc Interv Radiol 1:97–100
Yasumori K, Mahmoudi N, Wright KC, Wallace S, Gianturco C (1993) Placement of covered self-expanding metallic stents in the common bile duct: a feasibility study. J Vasc Interv Radiol 4:773–778
Saito H, Sakurai Y, Takamura A, Horio K (1994) Biliary endoprosthesis using Gore-Tex covered expandable metallic stent: preliminary clinical evaluation. Nippon Igaku Hoshasen Gakkai Zasshi 54:180–182
Miyayama S, Matsui O, Terayama N, Tatsu H, Yamamoto T, Takashima T (1997) Covered Gianturco stents for malignant biliary obstruction: preliminary clinical evaluation. J Vasc Interv Radiol 8:641–648
Rossi P, Bezzi M, Salvatori FM, Panzetti C, Rossi M, Pavia G (1997) Clinical experience with covered Wallstents for biliary malignancies: 23-month follow-up. Cardiovasc Intervent Radiol 20:441–447
Hausegger KA, Thurner S, Bodendorfer G et al (1998) Treatment of malignant biliary obstruction with polyurethane-covered Wallstents. AJR Am J Roentgenol 170:403–408
Bezzi M, Zolovkins A, Cantisani V, Salvatori FM, Rossi M, Fanelli F, Rossi P (2002) New ePTFE /FEP-covered stent in the palliative treatment of malignant biliary obstruction. J Vasc Interv Radiol 13(6):581–589, Jun
Kuo MD, Lopresti DC, Gover DD, Hall LD, Ferrara SL (2006) Intentional retrieval of Viabil stent-grafts from the biliary system. J Vasc Interv Radiol 17(2 Pt 1):389–397, Feb
Schoder M, Rossi P, Uflacker R, Bezzi M, Stadler A, Funovics MA, Cejna M, Lammer J (2002) Malignant biliary obstruction: treatment with ePTFE /FEP-covered endoprotheses-initial technical and clinical experience in a multicenter trial. Radiology 225:35–42
Hatzidakis A, Krokidis M, Kalbakis K, Romanos J, Petrakis I, Gourtsoyiannis N (2007) ePTFE /FEP-covered metallic stents for palliation of malignant biliary disease: can tumor ingrowth be prevented? Cardiovasc Interv Radiol 30(5):950–958
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fanelli, F., Orgera, G., Bezzi, M. et al. Management of malignant biliary obstruction: Technical and clinical results using an expanded polytetrafluoroethylene fluorinated ethylene propylene (ePTFE/FEP)-covered metallic stent after 6-year experience. Eur Radiol 18, 911–919 (2008). https://doi.org/10.1007/s00330-008-0852-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-008-0852-x